UniProt ID | NU133_HUMAN | |
---|---|---|
UniProt AC | Q8WUM0 | |
Protein Name | Nuclear pore complex protein Nup133 | |
Gene Name | NUP133 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1156 | |
Subcellular Localization | Nucleus, nuclear pore complex . Chromosome, centromere, kinetochore . Located on both the cytoplasmic and nuclear sides of the nuclear pore (PubMed:11564755). During mitosis, localizes to the kinetochores (PubMed:11564755). | |
Protein Description | Involved in poly(A)+ RNA transport.. | |
Protein Sequence | MFPAAPSPRTPGTGSRRGPLAGLGPGSTPRTASRKGLPLGSAVSSPVLFSPVGRRSSLSSRGTPTRMFPHHSITESVNYDVKTFGSSLPVKVMEALTLAEVDDQLTINIDEGGWACLVCKEKLIIWKIALSPITKLSVCKELQLPPSDFHWSADLVALSYSSPSGEAHSTQAVAVMVATREGSIRYWPSLAGEDTYTEAFVDSGGDKTYSFLTAVQGGSFILSSSGSQLIRLIPESSGKIHQHILPQGQGMLSGIGRKVSSLFGILSPSSDLTLSSVLWDRERSSFYSLTSSNISKWELDDSSEKHAYSWDINRALKENITDAIWGSESNYEAIKEGVNIRYLDLKQNCDGLVILAAAWHSADNPCLIYYSLITIEDNGCQMSDAVTVEVTQYNPPFQSEDLILCQLTVPNFSNQTAYLYNESAVYVCSTGTGKFSLPQEKIVFNAQGDSVLGAGACGGVPIIFSRNSGLVSITSRENVSILAEDLEGSLASSVAGPNSESMIFETTTKNETIAQEDKIKLLKAAFLQYCRKDLGHAQMVVDELFSSHSDLDSDSELDRAVTQISVDLMDDYPASDPRWAESVPEEAPGFSNTSLIILHQLEDKMKAHSFLMDFIHQVGLFGRLGSFPVRGTPMATRLLLCEHAEKLSAAIVLKNHHSRLSDLVNTAILIALNKREYEIPSNLTPADVFFREVSQVDTICECLLEHEEQVLRDAPMDSIEWAEVVINVNNILKDMLQAASHYRQNRNSLYRREESLEKEPEYVPWTATSGPGGIRTVIIRQHEIVLKVAYPQADSNLRNIVTEQLVALIDCFLDGYVSQLKSVDKSSNRERYDNLEMEYLQKRSDLLSPLLSLGQYLWAASLAEKYCDFDILVQMCEQTDNQSRLQRYMTQFADQNFSDFLFRWYLEKGKRGKLLSQPISQHGQLANFLQAHEHLSWLHEINSQELEKAHATLLGLANMETRYFAKKKTLLGLSKLAALASDFSEDMLQEKIEEMAEQERFLLHQETLPEQLLAEKQLNLSAMPVLTAPQLIGLYICEENRRANEYDFKKALDLLEYIDEEEDININDLKLEILCKALQRDNWSSSDGKDDPIEVSKDSIFVKILQKLLKDGIQLSEYLPEVKDLLQADQLGSLKSNPYFEFVLKANYEYYVQGQI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MFPAAPSP -------CCCCCCCC | 40.39 | 22223895 | |
7 | Phosphorylation | -MFPAAPSPRTPGTG -CCCCCCCCCCCCCC | 23.45 | 23401153 | |
9 | Methylation | FPAAPSPRTPGTGSR CCCCCCCCCCCCCCC | 58.87 | 115387851 | |
10 | Phosphorylation | PAAPSPRTPGTGSRR CCCCCCCCCCCCCCC | 29.47 | 25159151 | |
13 | Phosphorylation | PSPRTPGTGSRRGPL CCCCCCCCCCCCCCC | 32.94 | 25159151 | |
15 | Phosphorylation | PRTPGTGSRRGPLAG CCCCCCCCCCCCCCC | 20.74 | 22115753 | |
17 | Methylation | TPGTGSRRGPLAGLG CCCCCCCCCCCCCCC | 53.42 | 24129315 | |
27 | Phosphorylation | LAGLGPGSTPRTASR CCCCCCCCCCCCCCC | 38.07 | 22167270 | |
28 | Phosphorylation | AGLGPGSTPRTASRK CCCCCCCCCCCCCCC | 23.78 | 22167270 | |
30 | Methylation | LGPGSTPRTASRKGL CCCCCCCCCCCCCCC | 42.91 | - | |
31 | Phosphorylation | GPGSTPRTASRKGLP CCCCCCCCCCCCCCC | 30.13 | 25159151 | |
33 | Phosphorylation | GSTPRTASRKGLPLG CCCCCCCCCCCCCCC | 33.63 | 21712546 | |
35 | Acetylation | TPRTASRKGLPLGSA CCCCCCCCCCCCCCC | 63.40 | 26051181 | |
35 | Ubiquitination | TPRTASRKGLPLGSA CCCCCCCCCCCCCCC | 63.40 | 23000965 | |
41 | Phosphorylation | RKGLPLGSAVSSPVL CCCCCCCCCCCCCEE | 32.93 | 30266825 | |
44 | Phosphorylation | LPLGSAVSSPVLFSP CCCCCCCCCCEEECC | 28.74 | 29255136 | |
45 | Phosphorylation | PLGSAVSSPVLFSPV CCCCCCCCCEEECCC | 16.66 | 29255136 | |
50 | Phosphorylation | VSSPVLFSPVGRRSS CCCCEEECCCCCCCC | 17.95 | 29255136 | |
56 | Phosphorylation | FSPVGRRSSLSSRGT ECCCCCCCCCCCCCC | 33.98 | 26055452 | |
57 | Phosphorylation | SPVGRRSSLSSRGTP CCCCCCCCCCCCCCC | 30.38 | 23401153 | |
59 | Phosphorylation | VGRRSSLSSRGTPTR CCCCCCCCCCCCCCC | 21.67 | 22115753 | |
60 | Phosphorylation | GRRSSLSSRGTPTRM CCCCCCCCCCCCCCC | 39.77 | 23401153 | |
61 | Methylation | RRSSLSSRGTPTRMF CCCCCCCCCCCCCCC | 50.02 | 54557731 | |
63 | Phosphorylation | SSLSSRGTPTRMFPH CCCCCCCCCCCCCCC | 22.00 | 25159151 | |
65 | Phosphorylation | LSSRGTPTRMFPHHS CCCCCCCCCCCCCCC | 34.30 | 22115753 | |
72 | Phosphorylation | TRMFPHHSITESVNY CCCCCCCCCCCCCCC | 28.33 | 25159151 | |
74 | Phosphorylation | MFPHHSITESVNYDV CCCCCCCCCCCCCEE | 25.81 | 30108239 | |
76 | Phosphorylation | PHHSITESVNYDVKT CCCCCCCCCCCEECC | 13.65 | 30108239 | |
82 | Acetylation | ESVNYDVKTFGSSLP CCCCCEECCCCCCCC | 34.93 | 26051181 | |
82 | Sumoylation | ESVNYDVKTFGSSLP CCCCCEECCCCCCCC | 34.93 | - | |
82 | Ubiquitination | ESVNYDVKTFGSSLP CCCCCEECCCCCCCC | 34.93 | 21963094 | |
122 | Acetylation | ACLVCKEKLIIWKIA EEEEECCEEEEEEHH | 30.40 | 26051181 | |
131 | Phosphorylation | IIWKIALSPITKLSV EEEEHHCCCCCCHHH | 12.77 | 30266825 | |
134 | Phosphorylation | KIALSPITKLSVCKE EHHCCCCCCHHHHHH | 29.35 | 30266825 | |
135 | Acetylation | IALSPITKLSVCKEL HHCCCCCCHHHHHHC | 39.21 | 25953088 | |
135 | Ubiquitination | IALSPITKLSVCKEL HHCCCCCCHHHHHHC | 39.21 | 23000965 | |
140 | Ubiquitination | ITKLSVCKELQLPPS CCCHHHHHHCCCCCH | 60.34 | 23000965 | |
197 | Phosphorylation | LAGEDTYTEAFVDSG CCCCCEEEEEEECCC | 23.95 | - | |
213 | Phosphorylation | DKTYSFLTAVQGGSF CCEEEEEEEECCCEE | 23.83 | 28985074 | |
219 | Phosphorylation | LTAVQGGSFILSSSG EEEECCCEEEECCCC | 18.88 | 28985074 | |
223 | Phosphorylation | QGGSFILSSSGSQLI CCCEEEECCCCHHHE | 20.03 | - | |
227 | Phosphorylation | FILSSSGSQLIRLIP EEECCCCHHHEEECC | 24.62 | 28985074 | |
239 | Ubiquitination | LIPESSGKIHQHILP ECCCCCCCEEECCCC | 38.67 | - | |
253 | Phosphorylation | PQGQGMLSGIGRKVS CCCCCCCCCHHHHHH | 21.33 | 28555341 | |
258 | Ubiquitination | MLSGIGRKVSSLFGI CCCCHHHHHHHHHCC | 41.05 | - | |
260 | Phosphorylation | SGIGRKVSSLFGILS CCHHHHHHHHHCCCC | 25.10 | 22199227 | |
261 | Phosphorylation | GIGRKVSSLFGILSP CHHHHHHHHHCCCCC | 30.61 | 22199227 | |
267 | Phosphorylation | SSLFGILSPSSDLTL HHHHCCCCCCCCCCH | 22.33 | 22199227 | |
269 | Phosphorylation | LFGILSPSSDLTLSS HHCCCCCCCCCCHHH | 32.86 | 22199227 | |
270 | Phosphorylation | FGILSPSSDLTLSSV HCCCCCCCCCCHHHH | 39.77 | 22199227 | |
273 | Phosphorylation | LSPSSDLTLSSVLWD CCCCCCCCHHHHCCC | 29.59 | 22199227 | |
275 | Phosphorylation | PSSDLTLSSVLWDRE CCCCCCHHHHCCCCC | 17.11 | 22199227 | |
276 | Phosphorylation | SSDLTLSSVLWDRER CCCCCHHHHCCCCCC | 25.09 | 22199227 | |
285 | Phosphorylation | LWDRERSSFYSLTSS CCCCCCCCCEEECCC | 34.13 | 20860994 | |
287 | Phosphorylation | DRERSSFYSLTSSNI CCCCCCCEEECCCCC | 12.52 | 20860994 | |
288 | Phosphorylation | RERSSFYSLTSSNIS CCCCCCEEECCCCCC | 24.14 | 20860994 | |
290 | Phosphorylation | RSSFYSLTSSNISKW CCCCEEECCCCCCCE | 24.95 | 20860994 | |
291 | Phosphorylation | SSFYSLTSSNISKWE CCCEEECCCCCCCEE | 27.04 | 20860994 | |
292 | Phosphorylation | SFYSLTSSNISKWEL CCEEECCCCCCCEEC | 32.71 | 20860994 | |
295 | Phosphorylation | SLTSSNISKWELDDS EECCCCCCCEECCCC | 35.65 | 20860994 | |
296 | Ubiquitination | LTSSNISKWELDDSS ECCCCCCCEECCCCC | 40.67 | - | |
303 | Phosphorylation | KWELDDSSEKHAYSW CEECCCCCCCCCHHH | 58.62 | - | |
305 | Acetylation | ELDDSSEKHAYSWDI ECCCCCCCCCHHHHH | 35.17 | 26051181 | |
305 | Ubiquitination | ELDDSSEKHAYSWDI ECCCCCCCCCHHHHH | 35.17 | 29967540 | |
308 | Phosphorylation | DSSEKHAYSWDINRA CCCCCCCHHHHHHHH | 15.26 | 20068231 | |
309 | Phosphorylation | SSEKHAYSWDINRAL CCCCCCHHHHHHHHH | 21.03 | 20068231 | |
317 | Ubiquitination | WDINRALKENITDAI HHHHHHHHHCCCHHH | 47.97 | 21906983 | |
321 | Phosphorylation | RALKENITDAIWGSE HHHHHCCCHHHHCCC | 30.84 | 24114839 | |
329 | Phosphorylation | DAIWGSESNYEAIKE HHHHCCCCHHHHHHC | 46.54 | 28796482 | |
331 | Phosphorylation | IWGSESNYEAIKEGV HHCCCCHHHHHHCCC | 18.93 | 28796482 | |
335 | Ubiquitination | ESNYEAIKEGVNIRY CCHHHHHHCCCCCEE | 56.30 | 21906983 | |
450 | Phosphorylation | VFNAQGDSVLGAGAC EEECCCCCEECCCCC | 26.51 | 20068231 | |
465 | Phosphorylation | GGVPIIFSRNSGLVS CCCEEEEECCCCCEE | 21.83 | 20068231 | |
474 | Phosphorylation | NSGLVSITSRENVSI CCCCEEEECCCCEEE | 17.77 | 26471730 | |
475 | Phosphorylation | SGLVSITSRENVSIL CCCEEEECCCCEEEE | 35.61 | 26471730 | |
480 | Phosphorylation | ITSRENVSILAEDLE EECCCCEEEEEEHHC | 24.38 | 22817900 | |
489 | Phosphorylation | LAEDLEGSLASSVAG EEEHHCCCHHHHCCC | 16.04 | 30108239 | |
492 | Phosphorylation | DLEGSLASSVAGPNS HHCCCHHHHCCCCCC | 30.55 | 30108239 | |
493 | Phosphorylation | LEGSLASSVAGPNSE HCCCHHHHCCCCCCC | 15.47 | 30108239 | |
499 | Phosphorylation | SSVAGPNSESMIFET HHCCCCCCCCCEEEE | 33.89 | 26074081 | |
501 | Phosphorylation | VAGPNSESMIFETTT CCCCCCCCCEEEECC | 19.59 | 26074081 | |
506 | Phosphorylation | SESMIFETTTKNETI CCCCEEEECCCCCCC | 29.08 | 28102081 | |
507 | Phosphorylation | ESMIFETTTKNETIA CCCEEEECCCCCCCC | 28.68 | 28102081 | |
508 | Phosphorylation | SMIFETTTKNETIAQ CCEEEECCCCCCCCH | 39.01 | 28102081 | |
512 | Phosphorylation | ETTTKNETIAQEDKI EECCCCCCCCHHHHH | 30.89 | 29255136 | |
518 | Acetylation | ETIAQEDKIKLLKAA CCCCHHHHHHHHHHH | 40.77 | 26051181 | |
518 | Ubiquitination | ETIAQEDKIKLLKAA CCCCHHHHHHHHHHH | 40.77 | - | |
523 | Ubiquitination | EDKIKLLKAAFLQYC HHHHHHHHHHHHHHH | 48.37 | - | |
546 | Phosphorylation | MVVDELFSSHSDLDS HHHHHHHHCCCCCCC | 39.50 | 20068231 | |
547 | Phosphorylation | VVDELFSSHSDLDSD HHHHHHHCCCCCCCH | 21.48 | 20068231 | |
549 | Phosphorylation | DELFSSHSDLDSDSE HHHHHCCCCCCCHHH | 41.64 | 20068231 | |
553 | Phosphorylation | SSHSDLDSDSELDRA HCCCCCCCHHHHHHH | 50.78 | 29116813 | |
555 | Phosphorylation | HSDLDSDSELDRAVT CCCCCCHHHHHHHHH | 43.97 | 20068231 | |
575 | Phosphorylation | LMDDYPASDPRWAES CCCCCCCCCCHHHHC | 43.58 | 20860994 | |
582 | Phosphorylation | SDPRWAESVPEEAPG CCCHHHHCCCCCCCC | 34.91 | 28348404 | |
591 | Phosphorylation | PEEAPGFSNTSLIIL CCCCCCCCCCEEEEE | 45.15 | 28348404 | |
593 | Phosphorylation | EAPGFSNTSLIILHQ CCCCCCCCEEEEEEE | 24.58 | 24719451 | |
594 | Phosphorylation | APGFSNTSLIILHQL CCCCCCCEEEEEEEC | 23.09 | 28348404 | |
604 | Ubiquitination | ILHQLEDKMKAHSFL EEEECHHHHHHHHHH | 32.69 | - | |
606 | Ubiquitination | HQLEDKMKAHSFLMD EECHHHHHHHHHHHH | 49.00 | - | |
626 | Phosphorylation | GLFGRLGSFPVRGTP CCCCCCCCCCCCCCC | 30.85 | 25278378 | |
632 | Phosphorylation | GSFPVRGTPMATRLL CCCCCCCCCHHHHHH | 10.18 | 25278378 | |
636 | Phosphorylation | VRGTPMATRLLLCEH CCCCCHHHHHHHHHH | 18.65 | 25278378 | |
661 | Phosphorylation | KNHHSRLSDLVNTAI HCCHHHHHHHHHHHH | 27.99 | 28188228 | |
666 | Phosphorylation | RLSDLVNTAILIALN HHHHHHHHHHHHHHH | 13.95 | 28188228 | |
674 | Ubiquitination | AILIALNKREYEIPS HHHHHHHCCCCCCCC | 47.67 | 21906983 | |
677 | Phosphorylation | IALNKREYEIPSNLT HHHHCCCCCCCCCCC | 24.16 | 28796482 | |
681 | Phosphorylation | KREYEIPSNLTPADV CCCCCCCCCCCHHHH | 50.57 | 25159151 | |
684 | Phosphorylation | YEIPSNLTPADVFFR CCCCCCCCHHHHHHH | 22.23 | 27732954 | |
740 | Phosphorylation | KDMLQAASHYRQNRN HHHHHHHHHHHHHHH | 24.86 | 20068231 | |
755 | Phosphorylation | SLYRREESLEKEPEY HHHHCHHHHCCCCCC | 36.76 | 30108239 | |
758 | Acetylation | RREESLEKEPEYVPW HCHHHHCCCCCCCCC | 81.50 | 25953088 | |
758 | Ubiquitination | RREESLEKEPEYVPW HCHHHHCCCCCCCCC | 81.50 | 21906983 | |
762 | Phosphorylation | SLEKEPEYVPWTATS HHCCCCCCCCCCCCC | 23.64 | 23186163 | |
766 | Phosphorylation | EPEYVPWTATSGPGG CCCCCCCCCCCCCCC | 17.62 | 23186163 | |
768 | Phosphorylation | EYVPWTATSGPGGIR CCCCCCCCCCCCCEE | 27.17 | 23186163 | |
769 | Phosphorylation | YVPWTATSGPGGIRT CCCCCCCCCCCCEEE | 40.29 | 23186163 | |
787 | Acetylation | RQHEIVLKVAYPQAD ECCEEEEEEECCCCC | 17.58 | 25953088 | |
787 | Ubiquitination | RQHEIVLKVAYPQAD ECCEEEEEEECCCCC | 17.58 | 21906983 | |
832 | Phosphorylation | KSSNRERYDNLEMEY CCCCHHHHHHHHHHH | 12.39 | - | |
842 | 2-Hydroxyisobutyrylation | LEMEYLQKRSDLLSP HHHHHHHHHHHHHHH | 51.80 | - | |
842 | Ubiquitination | LEMEYLQKRSDLLSP HHHHHHHHHHHHHHH | 51.80 | 23000965 | |
908 | Ubiquitination | LFRWYLEKGKRGKLL HHHHHHHCCCCCCCC | 68.11 | - | |
913 | Ubiquitination | LEKGKRGKLLSQPIS HHCCCCCCCCCCCHH | 50.73 | 29967540 | |
961 | Phosphorylation | LGLANMETRYFAKKK HHHCCCCHHHHHHHH | 21.65 | - | |
967 | Ubiquitination | ETRYFAKKKTLLGLS CHHHHHHHHHHHHHH | 47.78 | 29967540 | |
968 | Ubiquitination | TRYFAKKKTLLGLSK HHHHHHHHHHHHHHH | 43.64 | 29967540 | |
969 | Phosphorylation | RYFAKKKTLLGLSKL HHHHHHHHHHHHHHH | 35.77 | - | |
975 | Ubiquitination | KTLLGLSKLAALASD HHHHHHHHHHHHHCC | 47.38 | 32015554 | |
981 | Phosphorylation | SKLAALASDFSEDML HHHHHHHCCCCHHHH | 39.78 | 20860994 | |
991 | Ubiquitination | SEDMLQEKIEEMAEQ CHHHHHHHHHHHHHH | 42.32 | 29967540 | |
1007 | Phosphorylation | RFLLHQETLPEQLLA HHHHCCCCCHHHHHH | 40.83 | 28348404 | |
1021 | Phosphorylation | AEKQLNLSAMPVLTA HHHCCCCCCCCCCCH | 22.81 | 25159151 | |
1027 | Phosphorylation | LSAMPVLTAPQLIGL CCCCCCCCHHHHHEE | 36.20 | - | |
1046 | Phosphorylation | ENRRANEYDFKKALD CCCCCCCCCHHHHHH | 26.87 | 28152594 | |
1049 | Ubiquitination | RANEYDFKKALDLLE CCCCCCHHHHHHHHH | 33.95 | 29967540 | |
1076 | Ubiquitination | LKLEILCKALQRDNW HHHHHHHHHHHCCCC | 49.00 | 32015554 | |
1084 | Phosphorylation | ALQRDNWSSSDGKDD HHHCCCCCCCCCCCC | 26.64 | - | |
1085 | Phosphorylation | LQRDNWSSSDGKDDP HHCCCCCCCCCCCCC | 24.86 | - | |
1086 | Phosphorylation | QRDNWSSSDGKDDPI HCCCCCCCCCCCCCC | 44.88 | - | |
1089 | Acetylation | NWSSSDGKDDPIEVS CCCCCCCCCCCCCCC | 65.04 | 26051181 | |
1089 | Ubiquitination | NWSSSDGKDDPIEVS CCCCCCCCCCCCCCC | 65.04 | 21906983 | |
1097 | Acetylation | DDPIEVSKDSIFVKI CCCCCCCHHHHHHHH | 61.75 | 26051181 | |
1097 | Ubiquitination | DDPIEVSKDSIFVKI CCCCCCCHHHHHHHH | 61.75 | 29967540 | |
1107 | Acetylation | IFVKILQKLLKDGIQ HHHHHHHHHHHCCCC | 52.95 | 25953088 | |
1107 | Ubiquitination | IFVKILQKLLKDGIQ HHHHHHHHHHHCCCC | 52.95 | 21890473 | |
1110 | Acetylation | KILQKLLKDGIQLSE HHHHHHHHCCCCHHH | 65.43 | 26051181 | |
1110 | Ubiquitination | KILQKLLKDGIQLSE HHHHHHHHCCCCHHH | 65.43 | 23000965 | |
1123 | Ubiquitination | SEYLPEVKDLLQADQ HHHCHHHHHHHHHHH | 40.78 | 33845483 | |
1133 | Phosphorylation | LQADQLGSLKSNPYF HHHHHCCCCCCCCCE | 41.01 | 30266825 | |
1135 | Ubiquitination | ADQLGSLKSNPYFEF HHHCCCCCCCCCEEE | 50.30 | 29967540 | |
1150 | Phosphorylation | VLKANYEYYVQGQI- EEECCCEEEECCCC- | 9.89 | 22817900 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
50 | S | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NU133_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NU133_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NU107_HUMAN | NUP107 | physical | 11564755 | |
NUP98_HUMAN | NUP98 | physical | 11564755 | |
NU107_HUMAN | NUP107 | physical | 17363900 | |
CENPF_HUMAN | CENPF | physical | 17363900 | |
SAP_HUMAN | PSAP | physical | 22939629 | |
NU107_HUMAN | NUP107 | physical | 19674973 | |
ELYS_HUMAN | AHCTF1 | physical | 26344197 | |
L10K_HUMAN | C19orf53 | physical | 26344197 | |
NU107_HUMAN | NUP107 | physical | 26344197 | |
ZMYM2_HUMAN | ZMYM2 | physical | 26344197 | |
WWOX_HUMAN | WWOX | physical | 24927568 | |
P121A_HUMAN | POM121 | physical | 24927568 | |
NUP50_HUMAN | NUP50 | physical | 24927568 | |
NU107_HUMAN | NUP107 | physical | 24927568 | |
RBP2_HUMAN | RANBP2 | physical | 24927568 | |
SENP2_HUMAN | SENP2 | physical | 24927568 | |
ELYS_HUMAN | AHCTF1 | physical | 24927568 | |
NUP98_HUMAN | NUP98 | physical | 24927568 | |
RL26L_HUMAN | RPL26L1 | physical | 24927568 | |
NU153_HUMAN | NUP153 | physical | 24927568 | |
LAP2A_HUMAN | TMPO | physical | 24927568 | |
LAP2B_HUMAN | TMPO | physical | 24927568 | |
RAF1_HUMAN | RAF1 | physical | 27173435 | |
NU107_HUMAN | NUP107 | physical | 27173435 | |
FTM_HUMAN | RPGRIP1L | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-7; THR-10; SER-27; THR-28; SER-45; SER-50 ANDSER-131, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-45; SER-50 AND SER-480,AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-7; THR-10; SER-27; THR-28; SER-45; SER-50 ANDSER-131, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27; THR-28; SER-41;SER-45 AND SER-50, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7; SER-45 AND SER-50,AND MASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-45 AND SER-50, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7; SER-57 AND SER-489,AND MASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-45 AND SER-50, AND MASSSPECTROMETRY. | |
"Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27; THR-28 AND SER-45,AND MASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-45 AND SER-50, AND MASSSPECTROMETRY. |